メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Chromosomal β-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum β-lactam antibiotics

  • Y. Arakawa
  • , M. Ohta
  • , N. Kido
  • , M. Mori
  • , H. Ito
  • , T. Komatsu
  • , Y. Fujii
  • , N. Kato

研究成果: ジャーナルへの寄稿学術論文査読

90   !!Link opens in a new tab 被引用数 (Scopus)

抄録

The chromosomally encoded β-lactamase gene of Klebsiella oxytoca E23004, a strain resistant to cefoperazone and aztreonam, was cloned and expressed in Escherichia coli HB101. The molecular mass and pI of this enzyme were 28 kilodaltons and 7.4, respectively. Although the β-lactamase of K. oxytoca hydrolyzed many cephalosporins, including broad-spectrum drugs, the nucleotide sequence and deduced amino acid sequence lacked homology with chromosomal class C β-lactamase genes (ampC) of E. coli or Citrobacter freundii. Rather, about 45% nucleotide sequence homology and 40% deduced amino acid sequence homology were observed between the K. oxytoca β-lactamase and TEM-1, a class A β-lactamase which does not efficiently hydrolyze cephalosporins. Values of K(m), relative V(max), and relative V(max)/K(m) for the K. oxytoca β-lactamase indicated that the enzyme is a penicillinase but that it can hydrolyze cefoperazone effectively and other broad-spectrum cephems weakly. Hence, the chromosomal β-lactamase of K. oxytoca E23004 belongs to class A but differences in its amino acid sequence provide a broader spectrum of activity.

本文言語英語
ページ(範囲)63-70
ページ数8
ジャーナルAntimicrobial agents and chemotherapy
33
1
DOI
出版ステータス出版済み - 1989
外部発表はい

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

All Science Journal Classification (ASJC) codes

  • 薬理学
  • 薬理学(医学)
  • 感染症

フィンガープリント

「Chromosomal β-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum β-lactam antibiotics」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル